PROF. CHRISTOPHER B UMBRICHT, MD, PHD
Osteopathic Medicine at Rutland Ave, Baltimore, MD
License number
Maryland D0034121
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
720 Rutland Ave, Baltimore, MD 21205
Phone
(410) 614-2662
Personal information
See more information about CHRISTOPHER B UMBRICHT at radaris.comName
Address
Phone
804 Huntsman Rd, Baltimore, MD 21286
804 Huntsman Rd, Towson, MD 21286
Professional information
Christopher Benedict Umbricht, Baltimore MD
Specialties:
Internal Medicine, Clinical Molecular Genetics
Work:
Johns Hopkins University
720 Rutland Ave, Baltimore, MD 21205
720 Rutland Ave, Baltimore, MD 21205
Education:
Universitat Basel (1982)
Dr. Christopher B Umbricht, Baltimore MD - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
720 Rutland Ave SUITE 756, Baltimore 21205
(410) 614-2662 (Phone)
SCHOOL OF MEDICINE JOHNS HOPKINS UNIV
720 Rutland Ave SUITE 844, Baltimore 21205
(410) 955-2774 (Phone), (410) 614-9775 (Fax)
(410) 614-2662 (Phone)
SCHOOL OF MEDICINE JOHNS HOPKINS UNIV
720 Rutland Ave SUITE 844, Baltimore 21205
(410) 955-2774 (Phone), (410) 614-9775 (Fax)
Certifications:
Internal Medicine, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Basel / Medical Faculty
U Hosp
St Claraspital
The Johns Hopkins Hospital
Johns Hopkins Onc Ctr
University of Basel / Medical Faculty
U Hosp
St Claraspital
The Johns Hopkins Hospital
Johns Hopkins Onc Ctr
Alternative Splice Variant Patterns Of Human Telomerase Reverse Transcriptase (Htert) In Thyroid Tumors To Distinguish Benign From Malignant
US Patent:
2010026, Oct 14, 2010
Filed:
Dec 5, 2008
Appl. No.:
12/746418
Inventors:
Martha Allen Zeiger - Baltimore MD, US
Jeanne Kowalski - Baltimore MD, US
Christopher Umbricht - Baltimore MD, US
Yongchun Wang - Baltimore MD, US
Jeanne Kowalski - Baltimore MD, US
Christopher Umbricht - Baltimore MD, US
Yongchun Wang - Baltimore MD, US
Assignee:
The Johns Hopkins University - Baltimore MD
International Classification:
A61K 51/00, C12Q 1/68, A61P 25/00
US Classification:
424 161, 435 6
Abstract:
This invention relates, e.g., to a method for determining if a thyroid tumor in a subject is malignant, comprising determining in a sample from the subject the amount of TERT (telomerase reverse transcriptase) mRNA which lacks the β sequence and the amount of TERT mRNA in the sample which comprises the β sequence, wherein a preponderance (e.g., at least about 55%) of TERT mRNA in the sample which comprises the β sequence indicates that the tumor is malignant, and wherein a preponderance of TERT mRNA which lacks the β sequence indicates that the tumor is not malignant.
Compositions And Methods For Characterizing And Treating Neoplasia
US Patent:
2012011, May 10, 2012
Filed:
Mar 10, 2010
Appl. No.:
13/255780
Inventors:
Radharani Marik - Baltimore MD, US
Christopher B. Umbricht - Baltimore MD, US
Martha A. Zeiger - Baltimore MD, US
Christopher B. Umbricht - Baltimore MD, US
Martha A. Zeiger - Baltimore MD, US
Assignee:
The John Hopkins University - Baltimore MD
International Classification:
C12Q 1/68, C07H 21/04, A61K 31/167, A61P 35/00, A61K 31/4353, A61K 31/165, A61K 31/166, A61K 31/706, A61K 31/593, A61K 31/19
US Classification:
514 43, 435 612, 514167, 536 2433, 514575, 514557, 514300, 514620
Abstract:
The invention features compositions and methods for characterizing the methylation status of the Vitamin D Receptor (VDR) in neoplasia (e.g., breast carcinoma), selecting an appropriate therapy, and treating the neoplasia (e.g., breast carcinoma).
Diagnostic Tool For Diagnosing Benign Versus Malignant Thyroid Lesions
US Patent:
2008014, Jun 19, 2008
Filed:
Apr 11, 2005
Appl. No.:
11/547995
Inventors:
Steven K. Libutti - North Potomac MD, US
Chiara Mazzanti - Pisa, IT
Martha Zeiger - Baltimore MD, US
Christopher Umbricht - Baltimore MD, US
Chiara Mazzanti - Pisa, IT
Martha Zeiger - Baltimore MD, US
Christopher Umbricht - Baltimore MD, US
International Classification:
C12Q 1/68, C12Q 1/02, C40B 30/06
US Classification:
435 6, 435 29, 506 9
Abstract:
The present invention relates to the use of genes differentially expressed in benign thyroid lesions and malignant thyroid lesions for the diagnosis and staging of thyroid cancer.
Diagnostic Tool For Diagnosing Benign Versus Malignant Thyroid Lesions
US Patent:
2010028, Nov 11, 2010
Filed:
Aug 27, 2008
Appl. No.:
12/675209
Inventors:
Martha Allen Zeiger - Bethesda MD, US
Nijaguna B. Prasad - Columbia MD, US
Steven K. Libutti - Potomac MD, US
Christopher B. Umbricht - Towson MD, US
Nijaguna B. Prasad - Columbia MD, US
Steven K. Libutti - Potomac MD, US
Christopher B. Umbricht - Towson MD, US
International Classification:
C40B 30/02, C12Q 1/68, C40B 30/00
US Classification:
506 8, 435 6, 506 7, 506 13, 506 14
Abstract:
The present invention relates to the use of genes differentially expressed in benign thyroid lesions and malignant thyroid lesions for the diagnosis and staging of thyroid cancer.
Method For Diagnosing The Stage Of A Thyroid Tumor
US Patent:
2011017, Jul 21, 2011
Filed:
Feb 10, 2011
Appl. No.:
13/024845
Inventors:
Steven K. Libutti - North Potomac MD, US
Chiara Mazzanti - Pisa, IT
Martha Zeiger - Baltimore MD, US
Christopher Umbricht - Baltimore MD, US
Chiara Mazzanti - Pisa, IT
Martha Zeiger - Baltimore MD, US
Christopher Umbricht - Baltimore MD, US
International Classification:
C40B 30/06, C12Q 1/68
US Classification:
506 10, 435 614, 435 611
Abstract:
The present invention relates to the use of genes differentially expressed in benign thyroid lesions and malignant thyroid lesions for the diagnosis and staging of thyroid cancer.
Osteopathic Medicine licenses in Maryland
EDUARDO DIEGO ABARCA ROJAS, Osteopathic Medicine, 8813 Waltham Woods Rd STE 204, Baltimore, MD 21234